Genetic diversity of HIV type 1 in Montenegro.

Human immunodeficiency virus type 1 (HIV-1) is characterized by high genetic variability due to its high replication rate and the lack of proofreading activity of the reverse transcriptase enzyme. On the basis of phylogenetic analysis performed on numerous isolates from all over the world, HIV-1 is subdivided into types, subtypes, subsubtypes, circulating recombinant forms, and unique recombinant forms. No data are currently available about the circulation of HIV-1 types in Montenegro. Here, we describe the genetic variability of HIV-1 strains identified in plasma samples of patients from Montenegro. Phylogenetic analysis on 32 HIV-1 sequences was carried out. The prevalent circulating HIV-1 subtype is B. The strains were interspersed within the tree. Two main clades (I and II) may suggest independent introductions of HIV-1 subtype B into Montenegro, although other epidemiological evidence will be needed to assume a small number of introductions. No obvious evidence of clustering by residence, age, or sex was found (data not shown). Nelfinavir resistance was found, though lopinavir is the only PI administered. Continuous monitoring of HIV-1-infected individuals is crucial to a better understand of the epidemiology of the B subtype in Montenegro.

[1]  D. Burke,et al.  Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. , 1995, AIDS research and human retroviruses.

[2]  T. Schulz,et al.  A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease , 2000, AIDS.

[3]  T. Jovanović,et al.  HIV-1 subtypes in Yugoslavia. , 2002, AIDS research and human retroviruses.

[4]  Tulio de Oliveira,et al.  The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. , 2008, AIDS research and human retroviruses.

[5]  H M Collett Mid-year report. , 1990, The Journal of air medical transport.

[6]  Deenan Pillay,et al.  Update of the Drug Resistance Mutations in HIV-1: December 2008 , 2008 .

[7]  G. Shaw,et al.  Molecular cloning and characterization of the HTLV-III virus associated with AIDS , 1984, Nature.

[8]  M. Ciccozzi,et al.  Phylogeographic reconstruction of HIV type 1B in Montenegro and the Balkan region. , 2012, AIDS research and human retroviruses.

[9]  O. Pybus,et al.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach , 2009, Retrovirology.

[10]  P. Sharp,et al.  Genetic diversity of HIV-1: the moving target. , 2000, AIDS.

[11]  F. Ceccherini‐Silberstein,et al.  Molecular diversity of HIV in Albania. , 2005, The Journal of infectious diseases.

[12]  F. McCutchan,et al.  Understanding the genetic diversity of HIV-1. , 2000, AIDS.

[13]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[14]  W. Heneine,et al.  Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006 , 2010, AIDS.

[15]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[16]  B. Margolin,et al.  Genetic variability of the human immunodeficiency virus: statistical and biological issues. , 1994, Annual review of genetics.

[17]  D. Richman,et al.  Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy , 2000, AIDS.